학술논문
MRD-Guided Zanubrutinib, Venetoclax and Obinutuzumab after an Optional Debulking with Bendamustine in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Primary Endpoint Analysis of the Phase 2 CLL2-Bzag Study
Document Type
Journal
Author
Furstenau, Moritz; Giza, Adam; Schneider, Christof; Tausch, Eugen; Robrecht, Sandra; Ritgen, Matthias; Bittenbring, Joerg; Hebart, Holger F.; Schoettker, Bjoern; Illert, Anna Lena; Graeven, Ullrich; Stoltefuss, Andrea; Heinrich, Bernhard; Eckert, Robert; Fink, Anna-Maria; Stumpf, Janina; Simon, Florian; Fischer, Kirsten; Al-Sawaf, Othman; Langerbeins, Petra; Kleinert, Fanni; Weiss, Jonathan; Kreuzer, Karl-Anton; Schilhabel, Anke; Brueggemann, Monika; Eichhorst, Barbara F.; Stilgenbauer, Stephan; Hallek, Michael; Cramer, Paula
Source
Subject
Language
English
ISSN
15280020